Literature DB >> 21279103

The clinical significance of hemoglobinopathies.

M A Ali, S C Wong.   

Abstract

Hemoglobinopathies may be a significant clinical problem in certain racial groups. A patient presenting with obscure hemolytic anemia should, therefore, be investigated for hemoglobinopathies, particularly if he is of Mediterranean or southeast Asian descent. Longterm iron therapy should not be instituted on the basis of a hypochromic microcytic blood picture without documenting iron deficiency. When investigating polycythemia in young patients with normal white blood cell and platelet counts, hemoglobin oxygen affinity (P50) should be measured.

Entities:  

Year:  1984        PMID: 21279103      PMCID: PMC2154213     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  8 in total

1.  A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin.

Authors:  V M INGRAM
Journal:  Nature       Date:  1956-10-13       Impact factor: 49.962

2.  [Not Available].

Authors:  H HORLEIN; G WEBER
Journal:  Dtsch Med Wochenschr       Date:  1948-10-15       Impact factor: 0.628

3.  Sickle cell anemia a molecular disease.

Authors:  L PAULING; H A ITANO
Journal:  Science       Date:  1949-11-25       Impact factor: 47.728

4.  Hemoglobin Bethesda, beta 145 (HC2) Tyr replaced by His, in a Canadian family.

Authors:  R M Schmidt; D L Jue; M A Ali; J Lyonnais; W F Moo-Penn
Journal:  Am J Clin Pathol       Date:  1976-08       Impact factor: 2.493

5.  Hemoglobinopathies in the Hamilton region. II. Thalassemia traits and iron therapy.

Authors:  M A Ali
Journal:  Can Med Assoc J       Date:  1975-03-22       Impact factor: 8.262

6.  Hemoglobin E, an oxidatively unstable mutation.

Authors:  H Frischer; J Bowman
Journal:  J Lab Clin Med       Date:  1975-04

7.  Inclusion-body beta-thalassemia trait. A form of beta thalassemia producing clinical manifestations in simple heterozygotes.

Authors:  G Stamatoyannopoulos; R Woodson; T Papayannopoulou; D Heywood; S Kurachi
Journal:  N Engl J Med       Date:  1974-04-25       Impact factor: 91.245

8.  A radioimmunoassay for serum ferritin.

Authors:  A W Luxton; W H Walker; J Gauldie; A M Ali; C Pelletier
Journal:  Clin Chem       Date:  1977       Impact factor: 8.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.